In a mouse model, the expression of miR-223-3p is upregulated in RA and results in suppression of IL-17 receptor D (IL-17RD) expression and may contribute to the pathogenesis of RA [57]. This evidence concerns the gene IL17RD and rheumatoid arthritis.